Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilene C Weitz

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Clinical Advances in Hematology & Oncology : H&O|July 1, 2025
Navigating the paroxysmal nocturnal hemoglobinuria (PNH) landscapeGloria F Gerber, Catherine M Broome, Ilene C Weitz
American Journal of Hematology|January 1, 2003
Thromboembolic complications of cancer: epidemiology, pathogenesis, diagnosis, and treatmentDouglas E Sutherland, Ilene C Weitz, Howard A Liebman
Clinical Advances in Hematology & Oncology : H&O|July 1, 2025
Practical approach to managing PNH: Q&AGloria F Gerber, Ilene C Weitz, Catherine M Broome
Platelets|March 28, 2018
Ethnic and racial difference in Helicobacter pylori infection in patients with immune thrombocytopenia treated at a major urban medical centerCaitlin M O'Neill, Ilene C Weitz, Casey O'Connell, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|April 7, 2007
Successful rituximab therapy of acquired factor VIII inhibitor in a patient with rheumatoid arthritisBruno Oliveira, Daniel G Arkfeld, Ilene C Weitz, et al.
Blood Transfusion = Trasfusione Del Sangue|December 17, 2013
Atypical haemolytic-uraemic syndrome due to heterozygous mutations of CFH/CFHR1-3 and complement factor H 479Preeti Chaudhary, Mehmet Hepgur, Sarmen Sarkissian, et al.
Blood Reviews|February 2, 2023
Biomarkers and laboratory assessments for monitoring the treatment of patients with paroxysmal nocturnal hemoglobinuria: Differences between terminal and proximal complement inhibitionAustin G Kulasekararaj, David J Kuter, Morag Griffin, et al.
Acta Haematologica|October 31, 2019
A Retrospective Study of the Combination of Rituximab, Cyclophosphamide and Dexamethasone for the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic AnemiaCaroline I Piatek, Hillel Bocian, Sandra Algaze, et al.
Investigational New Drugs|November 27, 2002
Does leucovorin alter the intratumoral pharmacokinetics of 5-fluorouracil (5-FU)? A Southwest Oncology Group studyCary A Presant, Joth Jacobson, Walter Wolf, et al.
Transfusion|May 20, 2015
Life-threatening delayed hyperhemolytic transfusion reaction in a patient with sickle cell disease: effective treatment with eculizumab followed by rituximabMark Boonyasampant, Ilene C Weitz, Brian Kay, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Clinical Advances in Hematology & Oncology : H&O|July 1, 2025
Navigating the paroxysmal nocturnal hemoglobinuria (PNH) landscapeGloria F Gerber, Catherine M Broome, Ilene C Weitz
American Journal of Hematology|January 1, 2003
Thromboembolic complications of cancer: epidemiology, pathogenesis, diagnosis, and treatmentDouglas E Sutherland, Ilene C Weitz, Howard A Liebman
Clinical Advances in Hematology & Oncology : H&O|July 1, 2025
Practical approach to managing PNH: Q&AGloria F Gerber, Ilene C Weitz, Catherine M Broome
Platelets|March 28, 2018
Ethnic and racial difference in Helicobacter pylori infection in patients with immune thrombocytopenia treated at a major urban medical centerCaitlin M O'Neill, Ilene C Weitz, Casey O'Connell, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|April 7, 2007
Successful rituximab therapy of acquired factor VIII inhibitor in a patient with rheumatoid arthritisBruno Oliveira, Daniel G Arkfeld, Ilene C Weitz, et al.
Blood Transfusion = Trasfusione Del Sangue|December 17, 2013
Atypical haemolytic-uraemic syndrome due to heterozygous mutations of CFH/CFHR1-3 and complement factor H 479Preeti Chaudhary, Mehmet Hepgur, Sarmen Sarkissian, et al.
Blood Reviews|February 2, 2023
Biomarkers and laboratory assessments for monitoring the treatment of patients with paroxysmal nocturnal hemoglobinuria: Differences between terminal and proximal complement inhibitionAustin G Kulasekararaj, David J Kuter, Morag Griffin, et al.
Acta Haematologica|October 31, 2019
A Retrospective Study of the Combination of Rituximab, Cyclophosphamide and Dexamethasone for the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic AnemiaCaroline I Piatek, Hillel Bocian, Sandra Algaze, et al.
Investigational New Drugs|November 27, 2002
Does leucovorin alter the intratumoral pharmacokinetics of 5-fluorouracil (5-FU)? A Southwest Oncology Group studyCary A Presant, Joth Jacobson, Walter Wolf, et al.
Transfusion|May 20, 2015
Life-threatening delayed hyperhemolytic transfusion reaction in a patient with sickle cell disease: effective treatment with eculizumab followed by rituximabMark Boonyasampant, Ilene C Weitz, Brian Kay, et al.
Pageof 4